Picture of Hofseth Biocare ASA logo

HBC Hofseth Biocare ASA News Story

0.000.00%
no flag iconLast trade - 00:00
Consumer DefensivesSpeculativeMicro CapSucker Stock

Brief: Hofseth Biocare Q1 Operating Revenues Of NOK 14.7 Mln VS NOK 14.8 Mln

May 10 (Reuters) - Hofseth Biocare ASA  HOFBC.OL :
    * HOFSETH BIOCARE HAD OPERATING REVENUES OF NOK 14.7M
(14.8M) IN
Q1 OF 2019
    * COST OF GOODS SOLD AMOUNTED TO NOK 10.9M (12.3M) IN
PERIOD.
OPERATIONAL PROFIT (EBITDA) FOR Q1 2019 WAS NEGATIVE NOK 12.9M
(14.9M)
    * EXPECT PROCESSED RAW MATERIAL TO CONTINUE INCREASING
DURING 2019
    * OPERATIONAL PROFIT (EBITDA) FOR Q1 2019 WAS NEGATIVE NOK
12.9M
(14.9M).
    * QTRLY EARNINGS PER SHARE (NOK) -0.07
    * CASH & CASH EQUIVALENTS FELL BY NOK 12.1M IN QUARTER,
LEAVING
TOTAL HOLDING OF CASH & CASH EQUIVALENTS AT NOK 36.5M BY END OF
PERIOD

Source text for Eikon:  ID:nGNEc5vXxv 
Further company coverage:  HOFBC.OL 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Hofseth Biocare ASA

See all news